Approval · Notice of Compliance 13151 · 2012
SABRIL: Notice of Compliance 13151
Issued March 26, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13151
- Date
- March 26, 2012
- Company
- Lundbeck Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph regarding pediatric use
- Therapeutic class
- Antiepileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SABRIL | Not yet assigned | — |
Medicinal ingredients
- VIGABATRIN 500 MG per PCK
- VIGABATRIN 500 MG per TAB